Pregnant women are screened for HBV to prevent perinatal transmission. If a pregnant woman is found to be HBV positive, the newborn should receive both the hepatitis B vaccine and hepatitis B immunoglobulin (HBIG) within 12 hours of birth to reduce the risk of infection.
